PB CPD Online e-learning site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2003) 27: 449-452. doi: 10.1192/pb.27.12.449
© 2003 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haw, C.
Right arrow Articles by Stubbs, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Haw, C.
Right arrow Articles by Stubbs, J.
Psychiatric Bulletin (2003) 27: 449-452
© 2003 The Royal College of Psychiatrists

Combined antipsychotics for ‘difficult-to-manage’ and forensic patients with schizophrenia: reasons for prescribing and perceived benefits

Camilla Haw, Consultant Psychiatrist and Jean Stubbs, Head of Pharmacy

St Andrew’s Hospital, Billing Road, Northampton, NN15DG

Declaration of interest

None.

AIMS AND METHOD

We aimed to examine reasons for initiating and continuing the prescription of combined antipsychotics. A structured interview was carried out with the responsible medical officers for 40 ‘difficult-to-manage’ tertiary referral patients with schizophrenia who were regularly treated with two or more antipsychotics.

RESULTS

Lack of efficacy of monotherapy was the main reason for initiating and continuing combined antipsychotics. Other reasons for continuing combined antipsychotics included not wishing to change medication as the patient was reasonably well, and safety considerations. Perceived benefits of combined antipsychotics included fewer positive symptoms and less disturbed behaviour.

CLINICAL IMPLICATIONS

‘Difficult-to-manage’ and forensic treatment-resistant patients with schizophrenia pose a particular therapeutic challenge. Use of combined antipsychotics, although not evidence-based, is perceived by some psychiatrists as beneficial when other options have failed.




This article has been cited by other articles:


Home page
Adv. Psychiatr. Treat.Home page
N. Abdelmawla and A. J. Mitchell
Sudden cardiac death and antipsychotics. Part 2: Monitoring and prevention
Advan. Psychiatr. Treat., March 1, 2006; 12(2): 100 - 109.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2003 The Royal College of Psychiatrists.